Literature DB >> 10022815

B-MYB transactivates its own promoter through SP1-binding sites.

A Sala1, B Saitta, P De Luca, M N Cervellera, I Casella, R E Lewis, R Watson, C Peschle.   

Abstract

B-MYB is an ubiquitous protein required for mammalian cell growth. In this report we show that B-MYB transactivates its own promoter through a 120 bp segment proximal to the transcription start site. The B-MYB-responsive element does not contain myb-binding sites and gel-shift analysis shows that SP1, but not B-MYB, protein contained in SAOS2 cell extracts binds to the 120 bp B-myb promoter fragment. B-MYB-dependent transactivation is cooperatively increased in the presence of SP1, but not SP3 overexpression. When the SP1 elements of the B-myb promoter are transferred in front of a heterologous promoter, an increased response to B-MYB results. In contrast, c-MYB, the prototype member of the Myb family, is not able to activate the luciferase construct containing the SP1 elements. With the use of an SP1-GAL4 fusion protein, we have determined that the cooperative activation occurs through the domain A of SP1. These observations suggest that B-MYB functions as a coactivator of SP1, and that diverse combinations of myb and SP1 sites may dictate the responsiveness of myb-target genes to the various members of the myb family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022815     DOI: 10.1038/sj.onc.1202421

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  B-myb and C-myb play required roles in neuronal apoptosis evoked by nerve growth factor deprivation and DNA damage.

Authors:  David X Liu; Subhas C Biswas; Lloyd A Greene
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

2.  Multilevel support vector regression analysis to identify condition-specific regulatory networks.

Authors:  Li Chen; Jianhua Xuan; Rebecca B Riggins; Yue Wang; Eric P Hoffman; Robert Clarke
Journal:  Bioinformatics       Date:  2010-04-07       Impact factor: 6.937

Review 3.  Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.

Authors:  Kenneth R Boheler
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

4.  CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition.

Authors:  Yassan Abdolazimi; Zhengshan Zhao; Sooyeon Lee; Haixia Xu; Paul Allegretti; Timothy M Horton; Benjamin Yeh; Hannah P Moeller; Robert J Nichols; David McCutcheon; Aryaman Shalizi; Mark Smith; Neali A Armstrong; Justin P Annes
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

Review 5.  B-Myb, cancer, senescence, and microRNAs.

Authors:  Ivan Martinez; Daniel Dimaio
Journal:  Cancer Res       Date:  2011-08-09       Impact factor: 12.701

6.  Egr-1 transactivates Bim gene expression to promote neuronal apoptosis.

Authors:  Bo Xie; Chong Wang; Zhihao Zheng; Bin Song; Chi Ma; Gerald Thiel; Mingtao Li
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

7.  MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells.

Authors:  Michael Papetti; Leonard H Augenlicht
Journal:  J Cell Physiol       Date:  2011-03       Impact factor: 6.384

8.  B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.

Authors:  Lucia Cicchillitti; Sergio A Jimenez; Arturo Sala; Biagio Saitta
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 9.  MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.

Authors:  Julian Musa; Marie-Ming Aynaud; Olivier Mirabeau; Olivier Delattre; Thomas Gp Grünewald
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

10.  Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.

Authors:  Ojore Oka; Lorna C Waters; Sarah L Strong; Nuvjeevan S Dosanjh; Vaclav Veverka; Frederick W Muskett; Philip S Renshaw; Karl-Heinz Klempnauer; Mark D Carr
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.